C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma

Autor: Rischin, D., Brungs, D., Day, F., Christie, H., Patel, V.A., Adams, G., Jackson, J.E., Schurmann, M.D.L.V., Kirtbaya, D., Shin, T.M., Hart, C.D., Stankevich, E., Li, S., Lowy, I., Han, H., Fury, M.G., Porceddu, S.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e610-e611
Databáze: ScienceDirect